A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...
A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Includes reviews of LaFontaine Chrysler Dodge Jeep Ram and Fiat of Lansing from DealerRater. Want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results